Fellowship
Chemical Pathology
MD Anderson Cancer Center, University of Texas
2003
Ali Ramadan, M.D. is an associate professor of pathology at Howard University Hospital and currently serves as the Medical Director of the Clinical Laboratory, a position he has held since 2021.
Ramadan began his postgraduate medical training with a residency in Ophthalmology at Hadassah Medical Center from 1992 to 1995. He subsequently came to the United States, where he conducted research at the National Institutes of Health (NIH) and completed fellowship training in Uveitis and Ocular Pathology.
He later completed residency training in Anatomic and Clinical Pathology at Howard University Hospital, followed by a fellowship in Chemical Pathology at The University of Texas MD Anderson Cancer Center in Houston, Texas. In 2011, he joined the faculty of Howard University Hospital, where he was appointed to the Department of Pathology and has since advanced to the rank of Associate Professor.
An accomplished educator, Ramadan has played a major role in the training of pathology residents, ophthalmology residents, medical students, and dental students. He has taught Clinical Chemistry and Laboratory Management to pathology residents and Ocular Pathology to ophthalmology residents. He currently directs small-group General Pathology teaching to second-year medical students.
Ramadan has received numerous awards in recognition of his dedication to patient care, education, and leadership, including the Patient Care Award, Teaching Excellence Award, Faculty of the Year Award, and Leadership Award.
His academic interests include laboratory medicine, clinical chemistry, ocular pathology, and ophthalmic diseases. He has authored and co-authored several peer-reviewed publications in ocular diseases and pathology and has contributed a book chapter on ocular Toxoplasmosis.
Chemical Pathology
MD Anderson Cancer Center, University of Texas
2003
Anatomic and Clinical Pathology
Howard University Hospital
2002
Ocular Pathology and Uveitis
National Eye Institute/NIH
1997
Ophthalmology
Hebrew University Hospital, Hadassah Medical Center
1994
Medicine
Amritsar Medical College
1981
Fellowship - Chemical Pathology, MD Anderson Cancer Center, University of Texas
Fellowship - Uveities and Ocular Pathology, National Eye Institute/NIH
Residency - Anatomic and Clinical Pathology, Howard University Hospital, Washington, D.C
Residency - Opthalmology, Hadassah Medical Center, Israel
Chapter 57 in Retina-Vitreous-Macula, A Comprehensive Textbook
This 2-volume set is the most comprehensive, authoritative, and up-to-date reference on vitreoretinal macular diseases available. Coverage begins with an in-depth exploration of clinical examination and diagnostic methods--including such advanced modalities as ICG angiography and 3D ultrasonography. Next, 100 individual chapters examine specific retinal disorders, including tumours. The final 26 chapters address specific surgical techniques and surgical disorders of the retina.
Temporal Efficacy Testing of Povidone-Iodine from an Open Bottle
To investigate the temporal efficacy and sterility of povidone-iodine (PI) against bacteria associated with postinjection endophthalmitis in an in vitro study.
Plasmacytoma of the Eyelid in an HIV-Positive Patient
Extramedullary (extraosseous) plasmacytoma represents a rare disease that accounts for less 5% of plasma cell neoplasms. It commonly occurs in the upper respiratory tract, with 80% of cases involving the paranasal sinuses, nasopharynx, or nasal cavity. Plasmacytomas of the eyelid are very rare with only ten cases having been reported in the literature so far. We present the clinical and histopathologic findings from a case of plasmacytoma of the eyelid and discuss its histopathologic differential diagnoses. To our knowledge, this is the first case of plasmacytoma of the eyelid in an HIV-positive patient in the English literature.
A Case Report of a Nerve Sheath Myxoma of the Lower Eyelid in a Young Male
Myxomas are rare, benign tumors of uncertain etiology. Based on the published data, there have been few reported cases of eyelid nerve sheath myxomas and two cases of orbital myxomas. Eyelid nerve sheath myxomas have a similar presentation to neurothekeoma of the myxoid variety, and historically these two diagnoses have been considered interchangeable. At present, the proper diagnosis can be found through protein immunoreactivity with histological staining. Currently in published literature, there has not been documentation of a family history with eyelid growth in patients diagnosed with nerve sheath myxomas. In this case report, we present a 19-year-old male with a potential third recurrence of nerve sheath myxoma who reports a family history of similar eyelid lesions.
The following case describes a 28-year old African American male who presented with squamous cell carcinoma of the lacrimal duct. Despite its size and location, his tumor showed complete resolution with non-surgical treatment.
The goal of this study is to gain insights into the early events of AMD that may lead to a better understanding of AMD’s pathogenesis, improve our preventative measures, and formulate designed therapeutic regimens that are tailored to target the initial pathological events.